Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Genmab A/S    GMAB   DK0010272202

GENMAB A/S

(GMAB)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 11/26 05:32:58 am
2280.5 DKK   +1.27%
11/25NOVARTIS : Genmab Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Genmab A/S : has published its Articles of Association

10/16/2020 | 10:19am EST

Genmab A/S has published its Articles of Association dated October 07, 2020.

The Articles of Association can be found on Genmab's website: https://ir.genmab.com/genmab-news.

Contact:

Marisol Peron

Tel: +1 609 524 0065

Email: mmp@genmab.com

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about GENMAB A/S
11/25NOVARTIS : Genmab Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
11/24GENMAB A/S : Announces Enapotamab Vedotin Update
AQ
11/24Genmab Announces Enapotamab Vedotin Update
GL
11/24GENMAB A/S : Mereo BioPharma Group plc - Mereo BioPharma Appoints Suba Krishnan,..
AQ
11/20IMMUNOPRECISE ANTIBODIES : and Genmab Enter into a Technology Partnership Target..
AQ
11/13GENMAB A/S : 2020 Virtual Capital Markets Day – November 13, 2020
PU
11/11GENMAB A/S : Articles of association dated November 10, 2020 – English
PU
11/11NOVARTIS : Capital Increase in Genmab as a Result of Employee Warrant Exercise
AQ
11/11NOVARTIS : Genmab to Present at Jefferies Virtual London Healthcare Conference
AQ
More news
Financials
Sales 2020 9 831 M 1 577 M 1 577 M
Net income 2020 4 665 M 748 M 748 M
Net cash 2020 15 037 M 2 412 M 2 412 M
P/E ratio 2020 31,3x
Yield 2020 -
Capitalization 147 B 23 574 M 23 630 M
EV / Sales 2020 13,5x
EV / Sales 2021 16,3x
Nbr of Employees 712
Free-Float 95,2%
Chart GENMAB A/S
Duration : Period :
Genmab A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENMAB A/S
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 2 194,34 DKK
Last Close Price 2 252,00 DKK
Spread / Highest target 33,2%
Spread / Average Target -2,56%
Spread / Lowest Target -89,9%
EPS Revisions
Managers
NameTitle
Jan G. J. van de Winkel President & Chief Executive Officer
Deirdre P. Connelly Chairman
Anthony Mancini Chief Operating Officer & Executive Vice President
Anthony Pagano Chief Financial Officer & Executive Vice President
Michael K. Bauer SVP, Head-Operations, Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
GENMAB A/S52.01%23 574
GILEAD SCIENCES, INC.-8.43%74 585
VERTEX PHARMACEUTICALS-0.39%56 714
REGENERON PHARMACEUTICALS35.38%53 649
WUXI APPTEC CO., LTD.55.32%37 691
BIONTECH SE209.80%25 273